Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
J Virol Methods. 2009 May;157(2):223-6. doi: 10.1016/j.jviromet.2008.12.011. Epub 2009 Jan 10.

Evaluation of a new West Nile Virus lateral-flow rapid IgM assay.

Author information

  • 1Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, United States. asambol@unmc.edu

Abstract

This study evaluated the performance of a new Food and Drug Administration-approved lateral-flow diagnostic screening test for qualitative detection of West Nile Virus (WNV) immunoglobulin M (IgM) in serum or plasma. Five public health laboratories across the United States performed retrospective testing on blinded serum samples from patients with physician reported diagnoses of WNV infection. The results of the RapidWN WNV IgM assay were compared with two commercially available WNV IgM enzyme-linked immunosorbent assays (EIA) and two public health-developed WNV-IgM tests. After discrepancies were resolved, the RapidWN WNV IgM EIA demonstrated a 98.8% sensitivity (range: 96.0-100%), a 95.3% specificity (range: 90.9-100%), a positive predictive value of 96.3% (range: 94.7-100%), and a negative predictive value of 98.4% (range: 95.5-100%), as compared to the predicate assays. The study results suggest that the RapidWN WNV IgM EIA is an effective, qualitative screening test that produces results comparable to that of predicate assays and can be employed rapidly to detect WNV IgM in patients suspected of having WNV infection.

PMID:
19138705
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk